WEC
ORGO icon

Winslow Evans & Crocker’s Organogenesis Holdings ORGO Stock Holding History

Winslow Evans & Crocker’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$2K Buy
+230
New +$1.09K ﹤0.01% 1233

Other funds holding ORGO

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Winslow Evans & Crocker's ORGO Position: Q4 2020 in Review

Winslow Evans & Crocker opened a new position in Organogenesis Holdings (ORGO) in Q4 2020: 230 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #1233 among its holdings.

67 funds tracked by Wall St. Rank hold ORGO as of Q4 2020.

  • Winslow Evans & Crocker held 230 shares of Organogenesis Holdings worth $2K as of Q4 2020.
  • Organogenesis Holdings was a new Winslow Evans & Crocker position in Q4 2020.
  • Organogenesis Holdings made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1233 holding.
  • 67 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.